These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32538358)

  • 1. Recalcitrant pemphigus successfully treated with lenalidomide.
    Zader J; Vucinic V; Simon JC; Treudler R
    Eur J Dermatol; 2020 Apr; 30(2):178-179. PubMed ID: 32538358
    [No Abstract]   [Full Text] [Related]  

  • 2. Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients).
    Jonasova A; Neuwirtova R; Polackova H; Siskova M; Stopka T; Cmunt E; Belickova M; Moudra A; Minarik L; Fuchs O; Michalova K; Zemanova Z
    Leuk Res; 2018 Jun; 69():12-17. PubMed ID: 29614393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the esophagus in a patient with pemphigus vulgaris who was on immunosuppressive therapy.
    Kanbay M; Selcuk H; Gur G; Yilmaz U; Boyacioglu S
    J Natl Med Assoc; 2006 Aug; 98(8):1369-70. PubMed ID: 16916141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent remission of severe rheumatoid arthritis associated with myelodysplastic syndrome upon treatment with lenalidomide.
    Carvès S; Birsen R; Avouac J
    Joint Bone Spine; 2024 May; 91(3):105693. PubMed ID: 38246576
    [No Abstract]   [Full Text] [Related]  

  • 5. Pemphigus vulgaris treated with adalimumab: case study.
    Vojáčková N; Fialová J; Vaňousová D; Hercogová J
    Dermatol Ther; 2012; 25(1):95-7. PubMed ID: 22591504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of refractory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy.
    Wever S; Zillikens D; Bröcker EB
    Br J Dermatol; 1996 Nov; 135(5):862-3. PubMed ID: 8977702
    [No Abstract]   [Full Text] [Related]  

  • 7. Curative treatment for pemphigus.
    Pasricha JS; Khaitan BK
    Arch Dermatol; 1996 Dec; 132(12):1518-9. PubMed ID: 8961890
    [No Abstract]   [Full Text] [Related]  

  • 8. Recalcitrant pemphigus foliaceus with Kaposi's varicelliform eruption: report of a fatal case.
    Demitsu T; Kakurai M; Azuma R; Hiratsuka Y; Yamada T; Yoneda K
    Clin Exp Dermatol; 2008 Aug; 33(5):681-2. PubMed ID: 18801107
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of topical cyclosporin in oral pemphigus.
    Gooptu C; Staughton RC
    J Am Acad Dermatol; 1998 May; 38(5 Pt 2):860-1. PubMed ID: 9591804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is mycophenolic acid effective for the treatment of pemphigus?
    Bystryn JC
    Arch Dermatol; 1999 Jul; 135(7):854-5. PubMed ID: 10411169
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged remission after immunosuppressive therapy in six dogs with pemphigus foliaceus.
    Olivry T; Bergvall KE; Atlee BA
    Vet Dermatol; 2004 Aug; 15(4):245-52. PubMed ID: 15305932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pemphigus vulgaris and intraepithelial neoplasia localized to the vagina].
    Hoareau F; Croue A; Marchetta J; Kettani S; Verret JL
    Ann Dermatol Venereol; 2007; 134(6-7):564-6. PubMed ID: 17657185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nail unit involvement during severe initial pemphigus vulgaris development.
    Apalla Z; Chaidemenos G; Karakatsanis G
    Eur J Dermatol; 2009; 19(3):290-1. PubMed ID: 19258233
    [No Abstract]   [Full Text] [Related]  

  • 15. Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study.
    De Simone C; Caldarola G; Perino F; Venier A; Guerriero G
    Dermatol Ther; 2012; 25(2):219-22. PubMed ID: 22741942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pemphigus vulgaris with mycophenolate mofetil.
    Enk AH; Knop J
    Lancet; 1997 Aug; 350(9076):494. PubMed ID: 9274594
    [No Abstract]   [Full Text] [Related]  

  • 17. Tinea incognito hidden under apparently treatment-resistant pemphigus foliaceus.
    Guenova E; Hoetzenecker W; Schaller M; Röcken M; Fierlbeck G
    Acta Derm Venereol; 2008; 88(3):276-7. PubMed ID: 18480931
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM; Albert S; Al Fares S; Harman KE; Setterfield J; Bhogal B; Black MM
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris.
    Craythorne EE; Mufti G; DuVivier AW
    J Am Acad Dermatol; 2011 Nov; 65(5):1064-5. PubMed ID: 22000877
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics and Management of Autoimmune Bullous Disease in Psoriasis Patients.
    Toh JJ; Lim YL; Yew YW
    Ann Acad Med Singap; 2019 Sep; 48(9):301-305. PubMed ID: 31737896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.